Abstract
Aromatic amino acid aminotransferases present a special potential in the production of drugs and synthons, thanks to their ability to accommodate a wider range of substrates in their active site, in contrast to aliphatic amino acid aminotransferases. The mechanism of active site adjustment toward substrates of psychrophilic aromatic amino acid aminotransferase (PsyArAT) from Psychrobacter sp. B6 is discussed based on crystal structures of complexes with four hydroxy-analogs of substrates: phenylalanine, tyrosine, tryptophan and aspartic acid. These competitive inhibitors are bound in the active center of PsyArAT but do not undergo transamination reaction, which makes them an outstanding tool for examination of the enzyme catalytic center. The use of hydroxy-acids enabled insight into substrate binding by native PsyArAT, without mutating the catalytic lysine and modifying cofactor interactions. Thus, the binding mode of substrates and the resulting analysis of the volume of the catalytic site is close to a native condition. Observation of these inhibitors’ binding allows for explanation of the enzyme’s adaptability to process various sizes of substrates and to gain knowledge about its potential biotechnological application. Depending on the character and size of the used inhibitors, the enzyme crystallized in different space groups and showed conformational changes of the active site upon ligand binding.
Highlights
Transamination stands as a bright example of reaction, which is nowadays conducted almost exclusively by biotechnological means. [1] Enzymatic methods allow to elude multistage and complicated chemical reactions and grant an enantiomerically pure product with high efficiency
Some of the enzyme-driven transamination products are useful in fields not related to pharmacy, for example, L-diphenylalanine, which is a substrate for the synthesis of peptide nanotubes that can be used as piezoelectric clean energy harvesters [16,17]
The aforementioned complexes crystallized in three space groups: hexagonal P65 22 for psychrophilic aromatic amino acid aminotransferase (PsyArAT)/DOH, monoclinic P21 for PsyArAT/FOH
Summary
Transamination stands as a bright example of reaction, which is nowadays conducted almost exclusively by biotechnological means. [1] Enzymatic methods allow to elude multistage and complicated chemical reactions and grant an enantiomerically pure product with high efficiency. [1] Enzymatic methods allow to elude multistage and complicated chemical reactions and grant an enantiomerically pure product with high efficiency. Aromatic amino acid aminotransferases (ArAT) play a crucial role in the biosynthesis and degradation of various biomolecules. They participate in several essential metabolic pathways: methionine, tyrosine and phenylalanine metabolism; phenylalanine, tyrosine and tryptophan biosynthesis; novobiocin biosynthesis and alkaloid biosynthesis. Some of the enzyme-driven transamination products are useful in fields not related to pharmacy, for example, L-diphenylalanine, which is a substrate for the synthesis of peptide nanotubes that can be used as piezoelectric clean energy harvesters [16,17]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.